Publications by authors named "Nerea Marcotegui"

Claim this Profile
S
Set Protein Is Involved in FLT3 Membrane Trafficking.
Nerea Marcotegui, Silvia Romero-Murillo, Javier Marco-Sanz, Irene Peris, Blanca S Berrozpe

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation.
Irene Peris, Silvia Romero-Murillo, Elena Martínez-Balsalobre, Caroline C Farrington, Elena Arriazu, Nerea Marcotegui

Blood· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.
Carmen Vicente, Elena Arriazu, Elena Martínez-Balsalobre, Irene Peris, Nerea Marcotegui

Cancer Lett· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia.
Elena Arriazu, Carmen Vicente, Raffaella Pippa, Irene Peris, Elena Martínez-Balsalobre, Nerea Marcotegui

Blood Cancer J· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia.
Raffaella Pippa, Ana Dominguez, Raquel Malumbres, Akinori Endo, Elena Arriazu, Nerea Marcotegui

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.
Miren Maicas, Iria Vázquez, Rafael Alis, Nerea Marcotegui, Leire Urquiza

Biochim Biophys Acta Gene Regul Mech· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia.
Eva Barragán, María Carmen Chillón, Remedios Castelló-Cros, Nerea Marcotegui, María Isabel Prieto

Haematologica· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.
Laura García-Ortí, Ion Cristóbal, Cristina Cirauqui, Elisabet Guruceaga, Nerea Marcotegui

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia.
Iria Vázquez, Miren Maicas, José Cervera, Xabier Agirre, Oskar Marin-Béjar, Nerea Marcotegui

Haematologica· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia.
Iria Vázquez, Miren Maicas, Nerea Marcotegui, Ana Conchillo, Elisabet Guruceaga

Proc Natl Acad Sci U S A· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia.
Ion Cristóbal, Francisco J Blanco, Laura Garcia-Orti, Nerea Marcotegui, Carmen Vicente

Blood· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis